Galapagos N.V. | Cash Flow

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
8,079.00
33,211.00
118,410.00
54,012.00
115,704.00
29,259
Depreciation, Depletion & Amortization
8,154.00
4,649.00
3,402.00
4,182.00
4,285.00
5,081
Other Funds
1,500.00
62,961.00
34,410.00
53,746.00
42,993.00
15,101
Funds from Operations
1,425.00
25,101.00
80,598.00
4,448.00
68,446.00
9,077
Changes in Working Capital
3,272.00
50,453.00
33,992.00
234,955.00
78,584.00
133,389
Net Operating Cash Flow
1,847.00
75,554.00
114,590.00
239,403.00
147,030.00
142,466
Capital Expenditures
7,873.00
2,804.00
6,665.00
4,790.00
7,437.00
Sale of Fixed Assets & Businesses
65.00
130,832.00
110.00
-
7.00
Purchase/Sale of Investments
-
-
-
2,750.00
371.00
Net Investing Cash Flow
11,988.00
120,606.00
4,297.00
7,287.00
549.00
Issuance/Reduction of Debt, Net
308.00
216.00
43.00
49.00
65.00
Net Financing Cash Flow
54,495.00
4,214.00
271,370.00
395,996.00
353,357.00
Net Change in Cash
43,806.00
49,537.00
152,602.00
632,927.00
177,970.00
Free Cash Flow
5,481.00
77,615.00
120,690.00
234,945.00
152,342.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
20.00
-
Net Assets from Acquisitions
1,152.00
-
-
-
-
Other Sources
-
-
2,258.00
253.00
6,510.00
Change in Capital Stock
54,803.00
4,430.00
271,413.00
396,045.00
353,422.00
Exchange Rate Effect
548.00
271.00
119.00
4,815.00
27,808.00
Other Uses
3,028.00
7,422.00
-
-
-

About Galapagos

View Profile
Address
Industriepark Mechelen Noord
Mechelen BU 2800
Belgium
Employees -
Website http://www.glpg.com
Updated 07/08/2019
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.